1. Japanese guidelines for non clinical studies of drugs manual. Tokyo: Yakuji Nippo; 1995.
2. ICH M3. Nonclinical safety studies for the conduct of human clinical trials for pharmaceuticals CPMP/ICH/288/95 1997.
3. ICHS7A. Note for guidance on safety pharmacology studies for human pharmaceuticals CPMP/ICH/539/00 2000.
4. Bonnes pratiques de laboratoire, arrêté ministériel du 14 mars, ministère du Travail, de l’Emploi et de la Solidarité.
5. ICHS7B. The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals CHMP/ICH/423/02 2005.